Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide (Q43810738)

27 November 2017

title

Glycemic control with Humalog Mix25 in type 2 diabetes inadequately controlled with glyburide (English)

1 reference

27 November 2017

1 reference

Roach

1

1 reference

27 November 2017

E Koledova

2

1 reference

27 November 2017

S Metcalfe

3

1 reference

27 November 2017

C Hultman

4

1 reference

27 November 2017

Z Milicevic

5

1 reference

27 November 2017

Romania/Russia Mix25 Study Group

6

1 reference

27 November 2017

publication date

1 October 2001

1 reference

27 November 2017

published in

Clinical Therapeutics

1 reference

27 November 2017

volume

23

1 reference

27 November 2017

issue

10

1 reference

27 November 2017

page(s)

1732-1744

1 reference

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980140-5

7 January 2021

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980140-5

7 January 2021

Nighttime insulin kinetics and glycemic control in type 1 diabetes patients following administration of an intermediate-acting lispro preparation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980140-5

7 January 2021

The narrow therapeutic window of glycated hemoglobin and assay variability

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980140-5

7 January 2021

The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980140-5

7 January 2021

Glucose intolerance and 23-year risk of coronary heart disease and total mortality: the Honolulu Heart Program

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980140-5

7 January 2021

The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980140-5

7 January 2021

Prevalence and atherosclerosis risk in different types of non-diabetic hyperglycemia. Is mild hyperglycemia an underestimated evil?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980140-5

7 January 2021

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980140-5

7 January 2021

Postprandial lipoproteins in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980140-5

7 January 2021

Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980140-5

7 January 2021

Well-being and symptoms in relation to insulin therapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2801%2980140-5

7 January 2021

10.1016/S0149-2918(01)80140-5

Identifiers

DOI

1 reference

27 November 2017

1 reference